Figure 3.
Flow cytometric analysis of peripheral blood lymphocyte populations in patients with CD3G mutations. (A) Representative flow cytometry plots for circulating CD4+ and CD8+ T lymphocytes in controls and CD3G-mutated patients. (B) Percentage of CD4+ (left) and CD8+ (right) T cells among PBMCs for control and CD3G-mutated patients. (C). Representative flow cytometry for Treg identification by FOXP3 and CD25 expression. (D) Percentage (left) of FOXP3+ Treg cells and FOXP3 mean fluorescence intensity (right) for controls and patients.

Flow cytometric analysis of peripheral blood lymphocyte populations in patients with CD3G mutations. (A) Representative flow cytometry plots for circulating CD4+ and CD8+ T lymphocytes in controls and CD3G-mutated patients. (B) Percentage of CD4+ (left) and CD8+ (right) T cells among PBMCs for control and CD3G-mutated patients. (C). Representative flow cytometry for Treg identification by FOXP3 and CD25 expression. (D) Percentage (left) of FOXP3+ Treg cells and FOXP3 mean fluorescence intensity (right) for controls and patients.

Close Modal

or Create an Account

Close Modal
Close Modal